Biovica Competitors and Similar CompaniesClear all
Biovica's competitors and similar companies include CSI Laboratories, Biocept, Universal Diagnostics and Biotheranostics.
 Biovica Biovica is a biotech company that develops and commercializes blood-based biomarker assays that help to monitor cancer therapies and predict patient outcomes. |  Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. |  Universal Diagnostics Universal Diagnostics (UDX) is a bioinformatics, multi-omics, and in-vitro diagnostics company that develops minimally invasive and blood-based solutions for detecting cancer. |  Biotheranostics Biotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. | ||
Founding Date | Founding Date 2009 | Founding Date 1997 | Founding Date 1993 | Founding Date 2012 | Founding Date 2008 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Uppsala, SE HQ Waltham, US | Locations Alpharetta, US HQ | Locations San Diego, US HQ | Locations Seville, ES HQ Ljubljana, SI Madrid, ES Cambridge, US | Locations San Diego, US HQ |
Employees | Employees 26 | Employees 1543% increase | Employees 878% decrease | Employees 1271% increase | Employees 971% decrease |
Valuation ($) | Valuation ($) 20.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) kr8.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods kr535k (FY, 2025) | Cost of goods N/A | Cost of goods $28.4m (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit kr8.1m (FY, 2025) | Gross profit N/A | Gross profit ($2.5m) (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income (kr87.6m) (FY, 2025) | Net income N/A | Net income ($32.1m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 15.9m | Total funding raised N/A | Total funding raised $ 32m |
For sources of this data, please see the company profile
View Company Profiles
CSI Laboratories
HQ
Alpharetta, US
Employees
154↑ 3% increase
CSI Laboratories is a cancer testing and diagnostics laboratory.
View companyBiocept
HQ
San Diego, US
Employees
87↓ 8% decrease
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
View companyUniversal Diagnostics
HQ
Seville, ES
Employees
127↑ 1% increase
Universal Diagnostics (UDX) is a bioinformatics, multi-omics, and in-vitro diagnostics company that develops minimally invasive and blood-based solutions for detecting cancer.
View companyBiotheranostics
HQ
San Diego, US
Employees
97↓ 1% decrease
Biotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients.
View company